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doi:10.1016/j.jfma.2012.03.014Although giant-cell tumor (GCT) of the bone was originally classified as a benign tumor, metas-
tasis has been reported. The radiographic features usually comprise parenchymal solitary or
multiple nodules that are round-to-oval nodular opacities of homogeneous density in patients
with GCT. However, the patient described in this case presented with a hypervascular mass
with feeding vessels and hemothorax, which are common features of pulmonary arteriovenous
malformation. To the best of our knowledge, cases of pulmonary metastases presenting as
a pulmonary arteriovenous malformation have not been reported. Here, we report a case of
giant-cell tumor of the bone that exhibited histologically benign pulmonary metastases and
mimicked an arteriovenous malformation.
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Giant-cell tumor (GCT) represents 5% of bone neoplasm and
typically occurs in 20e40-year-old patients.1 Although
these tumors are usually benign and locally destructive,& Formosan Medical Association. All rights reserved.
Figure 1 Radiograph of the distal femur shows a circumfer-
ential lucency around the bone cement.
370 C.D. Yeo et al.metastases have been reported in some patients.2 Recur-
rence is most common in the lung, but there have been case
reports of metastases at other sites, such as the lymph
nodes, bone, skin, and breast.2,3 Some patients with
pulmonary metastases have spontaneous regression or
remain asymptomatic for many years. Others have rapidly
progressive courses, even though they exhibit histologically
benign features. The overall mortality rate in patients with
pulmonary metastases is approximately 15%.1
In the case presented here, pulmonary metastasis of
a giant-cell tumor was proven to be the cause of hemo-
thorax. Moreover, the radiograph showed a hypervascular
mass with feeding vessels presenting as a pulmonary arte-
riovenous malformation, which is a rare manifestation of
pulmonary metastasis of giant-cell tumor.
Case report
A 22-year-old woman was admitted to the emergency
department presenting with severe dyspnea, chest pain,
and right pleural effusion on a chest film. She had been
diagnosed as having a GCT of the left distal femur 5 years
previously, and had undergone intraregional curettage fol-
lowed by methylmethacrylate bone cementing to fill the
defect. During follow-up on an outpatient basis, any
recurrence of the tumor was not occurred at the primary
site or evidence of a tumor in the chest. However, 1 month
before admission, the patient reported severe pain at the
site of the previous excision. Radiography showed local
recurrence of the tumor (Fig. 1). She was treated with
curettage, cementing, and internal fixation using a Locking
Compression Plate and screw.
On admission, blood pressure values were 100/60 mmHg;
the pulse rate was 100/min and regular. Decreased vesic-
ular breath sounds were heard over the right chest with
dullness to percussion. Hemoglobin was 8.4 g/dl with
normal red cell indexes, and the platelet count was normal.
Three-dimensional (3-D) helical computed tomography (CT)
revealed a well-defined oval and hypervascular mass in the
right lower lobe with feeding vessels, highly suggestive of
an arteriovenous malformation (Fig. 2). Paracentesis of the
hemothorax showed true blood and a right thoracotomy
was therefore performed. Thoracotomy revealed large
blood clots and a notable mass having feeding vessels in the
right lower lobe, up to 2 cm in dimension. She underwent
wedge resection and the mass was removed successfully.
The histological sections disclosed classic GCT metastasis
with benign natures (Fig. 3). She recovered without
sequelae and did not receive any adjuvant therapy. At
present, the patient is well and there is no apparent
recurrence at the primary tumor site or chest.
Discussion
GCT usually occurs in young adults and presents as an
epiphyseal osteolytic bone lesion. Although this type of
lesion was originally classified as a benign tumor, its
potential for metastasis has been reported variously in
1e9% of patients.2,3 A large study of 470 cases of GCT re-
ported an incidence of metastasis of 5.1%.3 The lung was
the most common site of metastasis (21 of 24 patients) andextrapulmonary metastasis was rare. Patients’ age and sex
are not risk factors for metastatic disease and there is no
predilection for the right or left side. The reported interval
between diagnosis of the primary tumor and detection of
metastasis ranges from 0 to 10 years (average, 3.5 years).3
Although a case of endobronchial metastasis has been re-
ported, metastatic lesions usually present as parenchymal
solitary or multiple nodules, that are round-to-oval nodular
opacities of homogeneous density.4e6
Although lung metastasis may spontaneously evolve into
necrosis or ossification, the treatment of lung metastases is
usually surgical resection.6 If removal of the lesion is
unfeasible, chemotherapy including adriamycin, dacarba-
zine, vincristine, cytoxan, actinomycin, or bleomycin can
control evolution of the disease.7 Radiotherapy is contra-
indicated because of the risk of induced malignancy. The
mortality of pulmonary metastatic GCT is variable and
uncertain, depending on the length of the follow-up. Cases
observed for 8 or 9 years exhibit a mortality of 14e23%,
suggesting the prognosis of a GCT with pulmonary metas-
tasis is quite favorable.8
Pulmonary arteriovenous malformation is a rare pulmo-
nary vascular anomaly. Although most patients are asymp-
tomatic, this malformation can cause dyspnea, hemoptysis,
hemothorax, and neurological complication because of
paradoxical embolism.9 The typical chest radiographic
feature of pulmonary arteriovenous malformation is
a round or oval mass of uniform density with prominent
feeding vessels that is frequently lobulated and ranges from
Figure 2 (A) Chest enhanced CT shows a large amount of
pleural effusion and a well-defined hyperdense nodule in the
right lower lobe. (B) 3-dimensional helical CT reveals hyper-
vascular lesion with feeding and draining vessels.
Pulmonary metastasis mimicking arteriovenous malformation 3711 to 5 cm in diameter.10,11 Chest enhanced computed
tomography (CT) is a valuable tool for the diagnosis and
definition of the vascular anatomy.12 However, pulmonary
angiography is the gold-standard diagnostic tool in this field
because of its enhanced ability to determine the
angioarchitecture.9 Since the report of the first successful
percutaneous embolization in 1978, embolotherapy using
coils or balloons has replaced surgical resection.13 SurgicalFigure 3 (A) The wedge resected right lower lobe shows a relat
rhage (H&E, 10). (B) High-magnification observation of nume
throughout ovoid mononuclear cells (H&E, 400).intervention is indicated in patients for whom embolo-
therapy failed or for those who developed serious bleeding
complications despite embolotherapy, had intrapleural
rupture of the pulmonary malformation, or had untreatable
contrast allergy or lesions that were not amendable to
embolotherapy.9
This patient had a oval, sharply defined hypervascular
mass with feeding vessels and hemothorax, which was
highly suggestive of pulmonary arteriovenous malforma-
tion radiographically. Although hemothorax is one of the
common complications of pulmonary venous malforma-
tion, spontaneous hemothorax has been reported as
a manifestation of tumor metastasis.14 In our patient, the
lesion was adjacent to pleura and hemothorax might have
resulted from rupture of a subpleural metastasis. To the
best of our knowledge, cases of pulmonary metastases
presenting as a hypervascular mass with feeding vessels
like a pulmonary arteriovenous malformation have not
been reported.
Although our patient had a “benign” metastasis to the
lung, about 5% of GCT patients have malignant trans-
formation.13 About half of these cases are associated with
previous irradiation.15 Immunohistochemical studies are
not required for the diagnosis of malignant transformation.
The diagnosis of malignant transformation depends on
observation of overt malignant cytological features,
including the presence of pleomorphic cells with vesicular
and irregularly shaped nuclei, prominent nucleoli, and
mitotic features.16
Patients with GCT usually require long-term follow-up.
In this case, we presumed the lesion was a pulmonary
arteriovenous malformation as indicated by both the clin-
ical presentation and the radiological features. This report
strongly suggests that follow-up of GCT, including local
recurrence, should include testing for evidence of pulmo-
nary metastasis. As a basal approach, patients should have
radiographs of the primary tumor site and of the chest
every 3 to 4 months for 2 years, every 6 months for the
following year, and annually thereafter. The presence of an
abnormality on chest radiography should be evaluated
further using CT.1ively well-demarcated mass, with central necrosis and hemor-
rous multinucleated giant cells distributed homogeneously
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